A process for the preparation of oxybutynin

By using bis(2-pyrimidinyl) carbonate (2-DPC) as a condensing agent, the problems of low yield and low purity in the preparation of oxybutynin were solved, and efficient industrial production was achieved.

CN121226262BActive Publication Date: 2026-11-10CHENGHONG PHARM (WEIHAI) CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202511468402.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2025-10-15
Publication Date
2026-11-10
Estimated Expiration
2045-10-15

AI Technical Summary

Technical Problem

Existing methods for preparing oxybutynin have low yields, low purity, and high costs for industrial production. In particular, the ester condensation step involves problems such as high reaction temperatures, long reaction times, or the need for complex purification.

Method used

Using bis(2-pyrimidinyl)carbonate (2-DPC) as a condensing agent, oxybutynin is generated by reacting 2-cyclohexyl-2-hydroxyphenylacetic acid and 4,4-diethylamino-2-butyn-1-ol in the presence of the catalyst 4-dimethylaminopyridine (DMAP). This avoids the use of strong bases and reduces the activation energy of ester condensation.

Benefits of technology

It improves the reaction yield and purity of oxybutynin, simplifies the post-processing, and is suitable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_3
    Figure SMS_3
  • Figure SMS_6
    Figure SMS_6
  • Figure QLYQS_1
    Figure QLYQS_1
Patent Text Reader

Abstract

The present application relates to a preparation method of oxybutynin, in particular, the present application provides a preparation method of condensing agent di(2-pyrimidinyl) carbonate and oxybutynin. The preparation method uses 2-cyclohexyl-2-hydroxyphenylacetic acid and 4,4-diethylamino-2-butyn-1-ol as raw materials, and di(2-pyrimidinyl) carbonate as a condensing agent for condensation reaction to prepare oxybutynin. The method can significantly improve the reaction yield and product purity, and the reaction condition is more mild.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of organic synthesis, and more specifically, this invention relates to a method for preparing oxybutynin. Background Technology

[0002] Oxybutynin is a commonly used anticholinergic drug. Clinically, it is available in two forms: oxybutynin or its hydrochloride salt (oxybutynin hydrochloride). Its chemical structure is shown below: .

[0003] Clinical studies have shown that this product is a tertiary amine antimuscarinic drug, with effects similar to atropine. It belongs to the parasympathetic nervous system and has strong smooth muscle relaxant effects, strong analgesic effects, weak anticholinergic effects, and local anesthetic effects. Clinically, it is used to treat urinary urgency, frequency, incontinence, and nocturnal enuresis; it is most suitable for urinary frequency symptoms caused by cystitis, urethritis, and recurrent urethral infections; it also has good efficacy in treating childhood enuresis.

[0004] Oxybutine has been prepared by various methods, but ester condensation is the key step that limits the yield and purity of the process.

[0005] The condensation methods reported in the literature can be mainly categorized as follows.

[0006] Method 1, the condensation method of carboxylic acids and alcohols, involves the condensation of a carboxylic acid compound (1) and an alcohol compound (2) in the presence of isobutyl chloroformate / triethylamine (IBCF / Et3N) or N-methylmorpholine / 1-hydroxybenzotriazole hydrate (EDCI / HOBt) to oxybutynin, which is then reacted with HCl to form oxybutynin hydrochloride. Literature involving this method includes WO200023414A2 (yield 68.9%) and US20090247628 A1 (yield 27%), and the reaction process can be summarized as follows: .

[0007] This method either involves high reaction temperatures, long reaction times, or requires complex purification methods such as column chromatography, resulting in a low overall yield.

[0008] Method 2, transesterification of esters and alcohols. This method involves the transesterification of ester compound (3) and alcohol compound (2) in the presence of a condensing agent and an organic base such as sodium methoxide to generate oxybutynin, which is then reacted with HCl to form oxybutynin hydrochloride. References involving this method include IN2009MU02349 A and CZ296056 B6, and the reaction process can be summarized as follows:

[0009] The method has a low conversion rate of raw materials, and due to the presence of strong base during post-processing, the newly formed ester bonds of the product oxybutynin are easily hydrolyzed into carboxylic acid compounds (1) and alcohol compounds (2), resulting in a decrease in yield and purity. Therefore, additional purification steps are required to improve product purity.

[0010] Method 3, ester-ester condensation method: This method involves the transesterification of an ester compound (3) and an alcohol compound (4) in the presence of a condensing organic base such as sodium methoxide to generate oxybutynin, which is then reacted with HCl to form oxybutynin hydrochloride. References involving this method include IN2008CH00297 A, etc., and the reaction process can be summarized as follows: .

[0011] This method reacts as in Method 2, and also suffers from low raw material conversion rate and the presence of strong alkali during post-processing, which easily leads to hydrolysis of oxybutynin, resulting in a decrease in yield and purity.

[0012] In summary, existing preparation methods mainly suffer from problems such as low yield, easy hydrolysis of products, or the need for multiple purifications. Therefore, there is a great need to develop a new, milder method with higher yield that is suitable for industrial production. Summary of the Invention

[0013] The purpose of this invention is to provide a method for synthesizing oxybutynin that is mild in operation, has a high yield, high purity, and is easy to industrialize. It mainly solves the technical problems of low yield, low purity, and high cost of industrial production of oxybutynin in existing methods. Technical solution

[0014] In a first aspect, the present invention provides a condensing agent, bis(2-pyrimidinyl) carbonate, abbreviated as 2-DPC, the chemical formula of which is shown in Formula I. .

[0015] Secondly, this application provides a method for preparing 2-DPC.

[0016] The method for preparing 2-DPC involves using 2-hydroxypyrimidine or 2-hydroxypyrimidine hydrochloride and triphosgene as raw materials, and triethylamine (Et3N) or N,N-diisopropylethylamine (DIPEA) as a base reagent, reacting in dichloromethane (DCM) or acetonitrile (ACN) solvents to obtain 2-DPC. The reaction formula is as follows:

[0017] Thirdly, this application provides a method for preparing oxybutynin, which includes the following steps: Oxybutynin was produced by reacting 2-cyclohexyl-2-hydroxyphenylacetic acid (compound 1) and 4,4-diethylamino-2-butyn-1-ol (compound 2) with the participation of condensing agent 2-DPC.

[0018] .

[0019] Preferably, the preparation method further includes a catalyst, wherein the catalyst is preferably 4-dimethylaminopyridine (DMAP).

[0020] The preparation method involves adding compound (1) to an organic solvent, adding an appropriate amount of catalyst (such as DMAP) and 2-DPC, then adding compound (2), and controlling the temperature until the reaction is complete to obtain oxybutynin, or continuing to form a salt to obtain oxybutynin hydrochloride.

[0021] Preferably, the organic solvent is selected from aprotic organic solvents, such as ether solvents like tetrahydrofuran, dioxane, methyltetrahydrofuran, etc., aromatic solvents like benzene, toluene, xylene, chlorobenzene, etc., amide solvents like DMF, NMP, etc., chlorinated hydrocarbon solvents like dichloromethane, chloroform, dichloroethane, carbon tetrachloride, etc., and others like acetonitrile, with toluene and dichloromethane being preferred.

[0022] Preferably, in the preparation method, the molar ratio of compound (1) to compound (2) is 1:0.8-1.5, preferably 1:1.

[0023] Preferably, in the preparation method, the molar ratio of compound (1) to catalyst is 1:0.05-0.15, preferably 1:0.1.

[0024] Preferably, in the preparation method, the molar ratio of compound (1) to condensing agent 2-DPC is 1:0.8-1.5, preferably 1:1.

[0025] Preferably, in the preparation method, the mass-volume ratio of compound (1) to the reaction solvent is 1:4.0-10.0, more preferably 1:6.0-10.0.

[0026] Preferably, in the preparation method, the reaction temperature is 0~80℃, more preferably 10~30℃.

[0027] In the preparation of oxybutynin, the condensing agent 2-DPC described in this application is presumed to primarily reduce the activation energy of ester condensation by generating an active ester intermediate (Formula II), thereby increasing the reaction conversion rate. The reaction process is presumed as follows: .

[0028] It is speculated that the electron-donating effect of the two N atoms in the pyrimidine structure makes the aromatic ring more electron-rich, thus making it easier to form active ester intermediates (Formula II), and the 2-hydroxypyrimidine is also more likely to leave during the later condensation, thereby making the reaction easier to proceed.

[0029] Beneficial effects: The 2-DPC condensing agent described in this application lowers the activation energy of ester condensation, making the reaction easier to carry out. It has the advantages of high reaction yield and high product purity, and avoids hydrolysis during product post-processing. Detailed Implementation To enable those skilled in the art to better understand the technical solutions of the present invention, some non-limiting embodiments are further disclosed below to provide a more detailed description of the present invention.

[0030] Example 1. Preparation of 2-(2-pyrimidinyl)carbonate, i.e., 2-DPC: 1330 ml of dichloromethane was added to a 2000 ml three-necked flask under nitrogen protection. 132.55 g (1.00 mol) of 2-hydroxypyrimidine hydrochloride was added, and the mixture was mechanically stirred and cooled to -10 ± 5 °C. 222.62 g (2.20 mol) of triethylamine was added dropwise while maintaining the temperature below 0 °C. After the addition was complete, the mixture was stirred at -10 ± 5 °C for 0.5 h. 148.36 g (0.50 mol) of triphosgene was added in portions while maintaining the temperature below -5 °C. After the addition was complete, the mixture was stirred at -10 ± 5 °C for 2–3 h. The reaction was stopped after TLC monitoring showed the reaction was complete. The reaction solution was filtered to remove salts, and the filtrate was concentrated under reduced pressure to remove the solvent. Add 520g of anhydrous ethanol, heat to 50-60℃ and keep warm for 15min, then slowly cool to 0-10℃ and keep warm for 0.5h, filter and wash with an appropriate amount of anhydrous ethanol, and dry the filter cake under reduced pressure at 60℃ to obtain 189.70g of white powder solid (yield 87.0%, HPLC purity > 99.0%). 1 H-NMR(400MHZ,DMSO-d6): δ=8.92(d,4H), δ=6.88(t,2H);MS(ESI + ):m / z=219.045[M+1] + .

[0031] Example 2. Preparation of oxybutynin hydrochloride.

[0032] Add 400 mL of dichloromethane to a 1000 mL three-necked flask. While mechanically stirring, add 50.00 g (0.2134 mol) of 2-cyclohexyl-2-hydroxyphenylacetic acid and 51.20 g (0.2347 mol) of 2-DPC. Then add 2.60 g (0.0213 mol) of 4-dimethylaminopyridine (DMAP). Stir at 25 ± 3 °C for 0.5 h. Add 36.16 g (0.2561 mol) of 4,4-diethylamino-2-butyn-1-ol. Stir and react at 25 ± 3 °C for 4–6 h. Once the mixture passes the control test, stop the reaction.

[0033] Wash twice with 400 ml of 10% NaH2PO4 solution, then wash once with 300 ml of purified water. Adjust the pH to 1-3 with an ethanol solution of hydrogen chloride, and remove the solvent from the organic phase under reduced pressure. Recrystallize with an appropriate amount of ethanol-n-hexane, and dry the wet product to obtain 78.77 g of pure oxybutynin hydrochloride (yield 93.7%, HPLC purity 99.99%).

[0034] Example 3. Preparation of oxybutynin hydrochloride.

[0035] Add 400 ml of dichloromethane to a 1000 ml three-necked flask. While mechanically stirring, add 50.00 g (0.2134 mol) of 2-cyclohexyl-2-hydroxyphenylacetic acid and 46.56 g (0.2134 mol) of 2-DPC, followed by 2.60 g (0.0213 mol) of DMAP. Stir at 30 ± 3 °C for 0.5 h. Then add 30.13 g (0.2134 mol) of 4,4-diethylamino-2-butyn-1-ol and stir at 30 ± 3 °C for 4–6 h. Once the mixture passes the control test, stop the reaction.

[0036] Wash twice with 400 ml of 10% NaH2PO4 solution, then wash once with 300 ml of purified water. Adjust the pH to 1-3 with ethanol hydrochloride solution, and remove the solvent from the organic phase under reduced pressure. Recrystallize with an appropriate amount of ethanol-n-hexane, and dry the wet product to obtain 75.83 g of pure oxybutynin hydrochloride (yield 90.2%, HPLC purity 99.98%).

[0037] Example 4. Preparation of oxybutynin hydrochloride.

[0038] Add 500 ml of toluene to a 1000 ml three-necked flask. Under mechanical stirring, add 50.00 g (0.2134 mol) of 2-cyclohexyl-2-hydroxyphenylacetic acid and 46.56 g (0.2134 mol) of 2-DPC, followed by 2.60 g (0.0213 mol) of DMAP. Stir at 25 ± 3 °C for 0.5 h. Then add 33.20 g (0.2351 mol) of 4,4-diethylamino-2-butyn-1-ol and stir at 10 ± 3 °C for 6–12 h. Once the mixture passes the control test, stop the reaction.

[0039] Wash twice with 400 ml of 10% NaH2PO4 solution, then wash once with 300 ml of purified water. Adjust the pH to 1-3 with ethanol hydrochloride solution, and remove the solvent from the organic phase under reduced pressure. Recrystallize with an appropriate amount of ethanol-n-hexane, and dry the wet product to obtain 77.68 g of pure oxybutynin hydrochloride (yield 92.4%, HPLC purity 99.98%).

[0040] Comparative Example 1. IBCF / Et3N was used as a condensing agent.

[0041] Nitrogen gas was purged from a 1000 ml three-necked flask, and 400 ml of cyclohexane was added. Under mechanical stirring, 20.00 g (0.0854 mol) of 2-cyclohexyl-2-hydroxyphenylacetic acid and 21.60 g (0.2135 mol) of triethylamine (Et3N) were added dropwise. 14.00 g (0.1025 mol) of IBCF was added dropwise at 20–30 °C, and the mixture was stirred at 25 ± 3 °C for 0.5 h. Then, 15.68 g (0.1110 mol) of 4,4-diethylamino-2-butyn-1-ol was added, and the mixture was heated to 65 °C and stirred for 4 h before the reaction was stopped.

[0042] Wash twice with 170 ml of 10% NaH2PO4 solution, then wash once with 170 ml of purified water. Adjust the pH to 1-3 with ethanol hydrochloride solution, and remove the solvent from the organic phase under reduced pressure. Recrystallize with an appropriate amount of ethanol-n-hexane, and dry the wet product to obtain 22.74 g of pure oxybutynin hydrochloride (yield 67.7%, HPLC purity 94.53%).

[0043] Comparative Example 2. N-methylmorpholine / 1-hydroxybenzotriazole hydrate (EDCI / HOBt) was used as a condensing agent.

[0044] Nitrogen gas was purged from a 1000 ml three-necked flask, and 500 ml of dichloromethane was added. Under mechanical stirring, 20.00 g (0.0854 mol) of 2-cyclohexyl-2-hydroxyphenylacetic acid and 12.06 g (0.0854 mol) of 4,4-diethylamino-2-butyn-1-ol were added, and the mixture was cooled to 0 °C. Then, 13.08 g (0.0854 mol) of 1-hydroxybenzotriazole hydrate (HOBt.H2O) and 26.01 g (0.2571 mol) of N-methylmorpholine were added sequentially. After the additions were complete, the mixture was stirred at 0 °C for 1 h. Finally, 29.46 g (0.1537 mol) of EDCI.HCl was added, and the mixture was stirred at 25 ± 3 °C for 16 h, at which point the reaction was stopped.

[0045] Wash twice with 170 ml of 10% NaH2PO4 solution, then wash once with 170 ml of purified water. Adjust the pH to 1-3 with ethanol hydrochloride solution, and remove the solvent from the organic phase under reduced pressure. Recrystallize with an appropriate amount of ethanol-n-hexane, and dry the wet product to obtain 8.68 g of pure oxybutynin hydrochloride (yield 25.8%, HPLC purity 96.73%).

[0046] Comparative Example 3. Sodium methoxide (MeONa) was used as a condensing agent.

[0047] Nitrogen gas was purged from a 500ml three-necked flask, and 212ml of cyclohexane was added. With mechanical stirring, 21.21g (0.0854mol) of methyl 2-cyclohexyl-2-hydroxyphenylacetate and 14.83g (0.1050mol) of 4,4-diethylamino-2-butyn-1-ol were added, and the temperature was raised to 83℃. Sodium methoxide (MeONa) was added in portions totaling 0.65g (0.0120mol). Methanol was slowly removed by distillation until the reaction ceased, at which point the reaction was stopped.

[0048] Cool to room temperature, wash once with 100 ml of purified water, then wash once with 15% Na2CO3 solution. Adjust the pH of the organic phase to 1-3 with 2N hydrochloric acid, then cool to 3-7℃ and keep warm for 3 hours to crystallize. Filter, and dry the wet product to obtain 25.16 g of pure oxybutynin hydrochloride (yield 74.8%, HPLC purity 93.45%).

[0049] The preferred embodiments of the present invention have been listed above, but they are not intended to limit the scope of the invention. Those skilled in the art will recognize that various modifications and variations can be made to these embodiments. Any modifications, equivalent substitutions, or improvements made to these embodiments without departing from the spirit and principles of the invention should be included within the scope of protection of the present invention.

Claims

1. A method for preparing oxybutynin, characterized in that, Includes the following steps: Oxybutynin is produced by reacting 2-cyclohexyl-2-hydroxyphenylacetic acid and 4,4-diethylamino-2-butyn-1-ol as raw materials in the presence of a compound of formula I. The specific steps are as follows: 2-cyclohexyl-2-hydroxyphenylacetic acid is added to an organic solvent, followed by the addition of a catalyst, 4-dimethylaminopyridine, and then the addition of the compound of formula I, followed by the addition of 4,4-diethylamino-2-butyn-1-ol, to obtain oxybutynin. The organic solvent is selected from one or more of tetrahydrofuran, dioxane, methyltetrahydrofuran, benzene, toluene, xylene, chlorobenzene, N,N-dimethylformamide, N-methylpyrrolidone, dichloromethane, chloroform, dichloroethane, carbon tetrachloride, and acetonitrile.

2. The method for preparing oxybutynin as described in claim 1, characterized in that, The molar ratio of 2-cyclohexyl-2-hydroxyphenylacetic acid to 4,4-diethylamino-2-butyn-1-ol is 1:0.8-1.

5.

3. The method for preparing oxybutynin as described in any one of claims 1 or 2, characterized in that, The molar ratio of 2-cyclohexyl-2-hydroxyphenylacetic acid to the catalyst 4-dimethylaminopyridine is 1:0.05-0.

15.

4. The method for preparing oxybutynin as described in any one of claims 1 or 2, characterized in that, The molar ratio of 2-cyclohexyl-2-hydroxyphenylacetic acid to the compound of formula 1 is 1:0.8-1.

5.

5. The method for preparing oxybutynin as described in any one of claims 1 or 2, characterized in that, The reaction temperature is 0 ~ 80℃.

6. The method for preparing oxybutynin as described in any one of claims 1 or 2, characterized in that, The molar ratio of 2-cyclohexyl-2-hydroxyphenylacetic acid to 4,4-diethylamino-2-butyn-1-ol is 1:

1.

7. The method for preparing oxybutynin as described in any one of claims 1 or 2, characterized in that, The molar ratio of 2-cyclohexyl-2-hydroxyphenylacetic acid to the catalyst 4-dimethylaminopyridine is 1:0.

1.

8. The method for preparing oxybutynin as described in any one of claims 1 or 2, characterized in that, The molar ratio of 2-cyclohexyl-2-hydroxyphenylacetic acid to the compound of formula 1 according to claim 1 is 1:

1.

9. The method for preparing oxybutynin as described in any one of claims 1 or 2, characterized in that, The reaction temperature is 10 ~ 30 ℃.

Citation Information

Patent Citations

  • Process for preparing oxybutynin

    CZ296056B6

  • Process for the preparation of form a of oxybutynin chloride

    IN2349MUM2009A

  • Crystalline oxybutynin and process for preparing the same

    IN297CHE2008A

  • Substituted phenylcyclohexylglycolates

    US20090247628A1

  • Synthesis of optically active cyclohexylphenylglycolic acid and its esters

    WO2000023414A2